Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • rglover
    rg
    • Dec 2008
    • 51

    #1

    454 and cluster operating systems - patching Fedora

    Hi everyone,

    We got our 454 and the titanium cluster about 3 months ago and we're having some issues with the 454, cluster and their operating systems. Our IT guys would be much happier if the operating systems were patched up to the latest versions. However, Roche have said that patching either OS will void the warranty.

    We're a medium/high security government institute and our IT guys are getting pretty jumpy about the out of date OS's - has anyone had the same issues? Is there another solution other than isolating the cluster and instrument in a separate subnet (as Roche are suggesting)?

    Cheers,
    Rachel
  • nickloman
    Senior Member
    • Jul 2009
    • 355

    #2
    We isolate our cluster on a private VLAN which can only be accessed by VPN.

    If you don't want to do that, I think your only solution would be to accept that you will void the warranty and just reinstall the cluster from scratch. Or chuck out the cluster and do it on your existing systems.

    You can download the Roche software and install it easily enough on a fresh Linux OS install. The cluster runs a fairly simple grid configuration which wouldn't be hard to replicate (for a competent Linux sysadm, not an average user).

    If you wanted to be really sneaky, you could create disk images for each machine in the cluster, store the images somewhere, go wild on the cluster and then if you ever did run into problems you could restore the cluster to its original factory state before Roche came to check up on it! That's a theoretical suggestion BTW

    Comment

    • nickloman
      Senior Member
      • Jul 2009
      • 355

      #3
      I should say, regardless of whether the OS is patched, it is probably good practice to isolate Linux servers from the outside world, unless they are a dedicated firewall/router box.

      Comment

      • rglover
        rg
        • Dec 2008
        • 51

        #4
        Thanks for the info - it's much appreciated!

        To the best of my knowledge they're both isolated from the outside world though (networks are a little over my head), but the out of date-ness of them is worrying our IT guys (for reasons I'm not entirely sure).

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 02:55 AM
        0 responses
        4 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...